Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol CD2 contributors: npt/mct - updated : 01-07-2009
HGNC name CD2 molecule
HGNC id 1639
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • N-terminus extracellular segment
  • two immunoglobulin superfamily domains
  • cytoplasmic tail containing no protein kinase as well as no phosphatase domains
  • conjugated GlycoP
    HOMOLOGY
    interspecies ortholog to murine Cd2
    Homologene
    FAMILY
    CATEGORY antigen
    SUBCELLULAR LOCALIZATION     plasma membrane
    basic FUNCTION
  • involved in antigen recognition via its role in adhesion and signal transduction
  • complex CD2/CD58 plays an important role in enhancing the adhesion of T lymphocytes to target cells, and promoting hyperplasia and activation of T lymphocytes (Li 2008)
  • receptor on T lymphocytes essential for T cell adhesion and stimulation by antigen presenting cells (APCs) (Zhu 2006)
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling signal transduction
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • interacting with CD58 prior antigen recognition by TCR (CD58 receptor)
  • SRBC receptor
  • LFA3 receptor
  • interacting with an adaptor protein (CDC2BP) to trigger cell adhesion
  • interaction with CD58 (interaction mediating tight adhesion within the 2D cell-cell interface) (Zhu 2006)
  • with CD58 up-regulate the expression of transcription factor FOXP3P3 leading to the enhanced function of CD4(+)CD25(high) regulatory T cells that are defective in subjects with MS (De Jager 2009)
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional     --over  
    significantly increased with the severity of chronic HBV infection, which suggested that CD2 might contribute to the hepatocyte damage in chronic HBV infection (Li 2008)
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS